Dr. William Bensinger, MD

Claim this profile

Swedish Cancer Institute

Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
3 reported clinical trials
10 drugs studied

Affiliated Hospitals

Image of trial facility.
Swedish Cancer Institute

Clinical Trials William Bensinger, MD is currently running

Image of trial facility.

BEAM vs. Melphalan

for Multiple Myeloma

The work proposed herein aims to provide the first prospective, randomized comparative efficacy data between Melphalan and BEAM treatment regimen in the Multiple Myeloma (MM) patient population. The risk of such a study is deemed reasonable and ethical since: a) previous works have closely examined the safety and toxicity of the BEAM regimen and the doses to be delivered in this protocol are well below the toxicity levels; b) phase III trials of BEAM have provided reasonable data regarding the efficacy in lymphomas c) Early, retrospective data suggests that BEAM may be efficacious in MM however due to the lack of prospective controlled randomized clinical trial, there is adequate equipoise regarding its efficacy and moreover its comparative efficacy in relation to Melphalan and; D) there are known limitations in the standard-of-care for MM, Melphalan, namely, relatively low rates of complete response at the time of Autologous stem-cell transplantation (ASCT) and poor progression free survival.
Recruiting1 award Phase 215 criteria

More about William Bensinger, MD

Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments William Bensinger, MD has experience with
  • Dexamethasone
  • Daratumumab
  • Carfilzomib
  • Lenalidomide
  • AO-176
  • Bortezomib
Breakdown of trials William Bensinger, MD has run
Multiple Myeloma
Plasma Cell Neoplasms

Other Doctors you might be interested in

Somasundaram Subramaniam, MDSwedish Cancer Institute
Daniel Egan, MDSwedish Cancer Institute
Philip Gold, MDSwedish Cancer Institute

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Bensinger, MD specialize in?
William Bensinger, MD focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is William Bensinger, MD currently recruiting for clinical trials?
Yes, William Bensinger, MD is currently recruiting for 1 clinical trial in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that William Bensinger, MD has studied deeply?
Yes, William Bensinger, MD has studied treatments such as Dexamethasone, Daratumumab, Carfilzomib.
What is the best way to schedule an appointment with William Bensinger, MD?
Apply for one of the trials that William Bensinger, MD is conducting.
What is the office address of William Bensinger, MD?
The office of William Bensinger, MD is located at: Swedish Cancer Institute, Seattle, Washington 98104 United States. This is the address for their practice at the Swedish Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top